SCHEMBL5596590

SCHEMBL5596590

NC(=O)C[C@@H](C(=O)O)N(O)c1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 2/20 0.39
SLC6A3 Q01959 3/20 0.39
DRD3 P35462 2/20 0.39
LMNA P02545 2/20 0.39
ADORA3 P0DMS8 1/20 0.39
EDNRB P24530 1/20 0.39
MAPK1 P28482 1/20 0.39
MC4R P32245 1/20 0.39
MC3R P41968 1/20 0.39
DRD2 P14416 1/20 0.39
ALDH1A1 P00352 5/20 0.37
RAB9A P51151 2/20 0.37
NPSR1 Q6W5P4 3/20 0.36
PKM P14618 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
ALOX5 P09917 1/20 0.36
SLC1A3 P43003 1/20 0.36
SLC1A2 P43004 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5596586 1.00 CYP2C19 (0.39) CYP2C19SLC6A3DRD3LMNAADORA3
SCHEMBL29011358 0.86 CA2 (0.39) CYP2C19LMNAALDH1A1CYP1A2CYP2D6
SCHEMBL27526065 0.85 CPA1 (0.43) CYP2C19LMNAMAPK1ALDH1A1RAB9A
SCHEMBL5595916 0.83 KMT2A (0.41) CYP2C19SLC6A3DRD3LMNAADORA3
SCHEMBL5595913 0.83 KMT2A (0.41) CYP2C19SLC6A3DRD3LMNAADORA3
SCHEMBL329145 0.81 NPSR1 (0.41) CYP2C19LMNAMAPK1ALDH1A1RAB9A
SCHEMBL329144 0.81 NPSR1 (0.41) CYP2C19LMNAMAPK1ALDH1A1RAB9A
SCHEMBL9283942 0.81 NPSR1 (0.41) CYP2C19LMNAMAPK1ALDH1A1RAB9A
SCHEMBL9283953 0.81 NPSR1 (0.41) CYP2C19LMNAMAPK1ALDH1A1RAB9A
SCHEMBL28426005 0.81 SLC6A2 (0.41) CYP2C19LMNAALDH1A1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7309719-B1 Storage stability; gabapentin and pregabalin, and neutral alpha -amino acid WARNER LAMBERT COMPANY, LLC (US) 2007-12-18 US disclosed
EP-1077692-B1 AMINO ACID STABILIZED GABAPENTIN AND PREGABALIN PREPARATIONS AND PROCESS FOR PREPARING THE SAME WARNER LAMBERT CO (US) 2004-07-28 EP disclosed
WO-1999059573-A9 STABILIZED PHARMACEUTICAL PREPARATIONS OF GAMMA-AMINOBUTYRIC ACID DERIVATIVES AND PROCESS FOR PREPARING THE SAME WARNER LAMBERT CO (US) 2000-05-04 WO disclosed